血浆蛋白联合临床因素构建肺结节风险评估模型
本研究基于磁纳米传感器检测七种血浆蛋白,结合临床因素用机器学习构建肺结节风险重分类模型(RRM),在训练队列(n=429)和验证队列(n=489)中评估,并与Mayo Clinic模型比较。RRM将中间风险患者比例从26.7%降至10.8%,低风险从16.8%升至21.9%,高风险从3.7%升至12.1%,在低风险阈值特异度和极高风险阈值敏感度均优于Mayo模型。
要点
- RRM基于七种血浆蛋白和六项临床因素,用支持向量机算法构建。
- RRM将中间风险患者比例从26.7%降至10.8%,重分类效果显著。
- RRM在低风险阈值特异度和极高风险阈值敏感度均优于Mayo模型。
核心结论
- RRM能准确将部分肺结节患者重分类为低风险和极高风险,有望改善风险分层。
研究设计与样本
- 基于磁纳米传感器开发七种血浆蛋白检测,在训练队列(n=429)用机器学习筛选算法,并在验证队列(n=489)评估,与Mayo Clinic模型比较。
主要发现
- 训练集支持向量机算法含七种血浆蛋白和六项临床因素,ROC曲线下面积0.87。
- RRM将中间风险患者比例从26.7%降至10.8%(P < .001)。
- RRM将低风险从16.8%升至21.9%(P < .001),高风险从3.7%升至12.1%(P < .001)。
- RRM低风险组真阴性/假阴性比为16.8,Mayo模型为19.5。
- RRM极高风险组真阳性/假阳性比为28.5,Mayo模型为17.0。
关键数值与推荐
- 风险分层标准:低≤10%,中10%-34%,中高35%-70%,高71%-84%,极高>85%。
- RRM在低风险阈值特异度更高,在极高风险阈值敏感度更高。
临床怎么用
- 对于肺结节患者,可结合血浆蛋白与临床因素使用RRM进行风险重分类,辅助识别低风险和极高风险人群。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Deficiencies in risk assessment for patients with pulmonary nodules (PNs) contribute to unnecessary invasive testing and delays in diagnosis. RESEARCH QUESTION: What is the accuracy of a novel PN risk model that includes plasma proteins and clinical factors? How does the accuracy compare with that of an established risk model? STUDY DESIGN AND METHODS: Based on technology using magnetic nanosensors, assays were developed with seven plasma proteins. In a training cohort (n = 429), machine learning approaches were used to identify an optimal algorithm that subsequently was evaluated in a validation cohort (n = 489), and its performance was compared with the Mayo Clinic model. RESULTS: In the training set, we identified a support vector machine algorithm that included the seven plasma proteins and six clinical factors that demonstrated an area under the receiver operating characteristic curve of 0.87 and met other selection criteria. The resulting risk reclassification model (RRM) was used to recategorize patients with a pretest risk of between 10% and 84%, and its performance was assessed across five risk strata (low, ≤ 10%; moderate, 10%-34%; intermediate, 35%-70%; high, 71%-84%; very high, > 85%). Stratification by the RRM decreased the proportion of intermediate-risk patients from 26.7% to 10.8% (P < .001) and increased the low-risk and high-risk strata from 16.8% to 21.9% (P < .001) and from 3.7% to 12.1% (P < .001), respectively. Among patients classified as low risk by the RRM and Mayo Clinic model, the corresponding true-negative to false-negative ratios were 16.8 and 19.5, respectively. Among patients classified as very high risk by the RRM and Mayo Clinic model, the corresponding true-positive to false-positive ratios were 28.5 and 17.0, respectively. Compared with the Mayo Clinic model, the RRM provided higher specificity at the low-risk threshold and higher sensitivity at the very high-risk threshold. INTERPRETATION: The RRM accurately reclassified some patients into low-risk and very high-risk categories, suggesting the potential to improve PN risk assessment.
引用
- Vachani A, Lam S, Massion PP, et al. Development and Validation of a Risk Assessment Model for Pulmonary Nodules Using Plasma Proteins and Clinical Factors. Chest. 2022. PMID: 36368616. doi:10.1016/j.chest.2022.10.038
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。